Breaking News
Get 40% Off 0
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks. Unlock full list
Close

Bio-Techne Corp (TECH)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Bio-Techne's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
82.50 -1.31    -1.56%
20/05 - Closed. Currency in USD ( Disclaimer )
Pre Market
81.93
-0.57
-0.69%
8:00:03 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 1,006,915
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 82.38 - 84.22
Bio-Techne 82.50 -1.31 -1.56%

Bio-Techne Corp Company Profile

 
Get an in-depth profile of Bio-Techne Corp, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

3050

Equity Type

ORD

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets in the United States, the United Kingdom, rest of Europe, Middle East, and Africa, Greater China, rest of Asia-Pacific, and internationally. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.

Contact Information

Address 614 McKinley Place N.E.
Minneapolis, 55413
United States
Phone 612 379 8854
Fax 612 656 4400

Top Executives

Name Age Since Title
Robert V. Baumgartner 65 2003 Independent Chairman of the Board
Kim Kelderman 56 2018 CEO, President & Director
John L. Higgins 54 2009 Independent Director
David Artis - - Member of Scientific Advisory Board
Charles R. Kummeth 64 2013 Senior Advisor & Director
Randolph C. Steer 74 1990 Independent Director
John M. Denu - - Member of Scientific Advisory Board
Roeland Nusse 74 2010 Independent Director
Julie L. Bushman 63 2020 Independent Director
Sachdev Sidhu - - Member of Scientific Advisory Board
Joseph D. Keegan 70 2017 Independent Director
Alpna H. Seth 61 2017 Independent Director
S. J. Rupert Vessey 59 2019 Independent Director
Judith V. Klimovsky 66 2024 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

TECH Comments

Write your thoughts about Bio-Techne Corp
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Oleh Feshchenko
Oleh Feshchenko Feb 05, 2024 6:01AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
nice
Thị Mỹ Thuận Trần
Thị Mỹ Thuận Trần Feb 11, 2022 9:08AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
OMG, P/E =82 .
air man
air man Jul 16, 2021 8:30AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
AIRI and TECH are good stocks
Gavin Tse
Gavin Tse Jul 16, 2021 8:30AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
AIRI? Seriously?
Lester Regina
Lester Regina Mar 19, 2021 7:35PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Products like AR glasses and AR helmets will become more and more in the next three years.
emre kaplan
emre kaplan May 09, 2020 12:21PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
come to rtalb🇹🇷
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email